FBRNX
Price
$86.50
Change
+$0.82 (+0.96%)
Updated
Dec 24 closing price
VTSAX
Price
$144.66
Change
+$1.55 (+1.08%)
Updated
Dec 24 closing price
Ad is loading...

FBRNX vs VTSAX

Header iconFBRNX vs VTSAX Comparison
Open Charts FBRNX vs VTSAXBanner chart's image
Fidelity Advisor Stock Sel All Cp I
Price$86.50
Change+$0.82 (+0.96%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.66
Change+$1.55 (+1.08%)
VolumeN/A
CapitalizationN/A
FBRNX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBRNX vs. VTSAX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBRNX is a Buy and VTSAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.84T vs. FBRNX (7.67B). VTSAX pays higher dividends than FBRNX: VTSAX (1.35) vs FBRNX (0.58). FBRNX was incepted earlier than VTSAX: FBRNX (12 years) vs VTSAX (24 years). FBRNX is a more actively managed with annual turnover of: 7.00 vs. VTSAX (2.00). FBRNX has a lower initial minimum investment than VTSAX: FBRNX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 25.73 vs. FBRNX (23.55). VTSAX return over 5 years is better than : 81.67 vs. FBRNX (72.58).
FBRNXVTSAXFBRNX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years24 years-
Gain YTD22.97425.37091%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.67B1.84T0%
Annual Yield % from dividends0.581.3543%
Returns for 1 year23.5525.7392%
Returns for 3 years24.7024.29102%
Returns for 5 years72.5881.6789%
Returns for 10 years146.33187.5778%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK10.660.40
+3.90%
CleanSpark
STEL28.770.11
+0.38%
Stellar Bancorp
DOW40.090.12
+0.30%
Dow
MG8.77-0.12
-1.35%
Mistras Group
SABS4.10-0.18
-4.21%
SAB Biotherapeutics